REMOTE RESULTS OF TREATMENT IN PATIENTS WITH PULMONARY TUBERCULOSIS AND PREVIOUS INEFFECTIVE THERAPY

Authors

  • Dmitriy Sergeevich RYASENSKIY Tver State Medical University of the Ministry of Health of the Russian Federation, Department of Phthisiology, 170100, Tver, Russia
  • Alexander Vladimirovich ASEEV Tver State Medical University of the Ministry of Health of the Russian Federation, Department of Phthisiology, 170100, Tver, Russia
  • Akhmed Ibragimovich ELGALI Tver State Medical University of the Ministry of Health of the Russian Federation, Department of Phthisiology, 170100, Tver, Russia

DOI:

https://doi.org/10.52692/1857-0011.2021.3-71.16

Keywords:

Pulmonary tuberculosis, anti-tuberculosis treatment, anti-tuberculosis drugs

Abstract

Until recently, bedaquiline and linezolid were relatively unavailable in antituberculosis dispensaries. Patients that neededthese drugs were directed to specialized Federal antituberculosis institutions. The study was aimed to evaluate remote resultsof the treatment of patients with drug-resistant pulmonary tuberculosis who had previous ineffective therapy at a local antituberculosis dispensary and directed to specialized Federal antituberculosis institutions. A total of 143 patients of both sexesaged 20-60 years old were examined. These patients received therapy at the Tver Regional Clinical Antituberculosis Dispensary in 2010-2014. To increase adherence to the treatment, a complex of measures were taken that included an individualsession with a specialist, organization of communication with other patients that received effective therapy for tuberculosis,and watching of an educational video. A complex of measures on an increase in the adherence to the treatment among patientswith pulmonary tuberculosis provided positive results in 143 patients. These patients agreed to possible surgical interventionin the Federal Antituberculosis Institution. After the surgical treatment, cavity closure and/or abacillation were registered in132 patients. Adherence to the consumption of antituberculosis drugs significantly increased in the studied patients.

Author Biographies

Dmitriy Sergeevich RYASENSKIY, Tver State Medical University of the Ministry of Health of the Russian Federation, Department of Phthisiology, 170100, Tver, Russia

Candidate of Medical Sciences, Associate Professor at the Department of
Phthisiology

Alexander Vladimirovich ASEEV, Tver State Medical University of the Ministry of Health of the Russian Federation, Department of Phthisiology, 170100, Tver, Russia

Doctor of Medical Sciences, Head of the Department of Phthisiology

Akhmed Ibragimovich ELGALI, Tver State Medical University of the Ministry of Health of the Russian Federation, Department of Phthisiology, 170100, Tver, Russia

Phthisiology Akhmed Ibragimovich ELGALI, A

References

Рясенский Д.С., Гришкина Н.А., Асеев А.В. Влияние туберкулезной инфекции и противотуберкулезной химиотерапии на липидный состав плазмы крови. Эпидемиология и инфекционные болезни. – 2018; 23(5): 220-224

Eskild P.J., Farah M.J., Giuseppe I, Alimuddin Z. Latent tuberculosis infection: diagnostic tests and when to treat. Lancet Infect Dis 2019; 19: 231-234.

Kathrin Z, Marie B, Prof L.F., Sonia B, Peter M.K., Joachim G, et al. Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study. Lancet Infect Dis 2019; 19: 298-307.

Timothy D.H., Isobella H, Marc L, Alimuddin Z Revolutionary new treatment regimens for multidrug-resistant tuberculosis. Lancet Infect Dis 2019; 19: 233-235.

Рясенский, Д. С. Клиническая эффективность применения препаратов, содержащих глицирризиновую кислоту, у больных туберкулезом легких / Д. С. Рясенский, А. В. Асеев, Н. А. Гришкина // Туберкулез и социально-значимые заболевания. – 2019; 4: 27-31.

Downloads

Published

2021-11-17

Issue

Section

Research Article